ALERT: ANTI-COMPETITIVE PRACTICE - PAY FOR DELAY - PATENT

Pay for delay : The General Court of the European Union confirms the Commission’s approach (Lundbeck)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On 8 September 2016, the General Court of the European Union delivered 6 judgements in the Lundbeck case, named after the Danish originator pharmaceutical company sanctioned by the European Commission for implementing a pay-for-delay practice: Case T-460/13 (Sun Pharmaceutical Industries and Ranbaxy/Commission) ; Case T- 467/13 (Arrow Group and Arrow Generics/Commission) ; Case T-469/13 (Generics (UK)/Commission) ; Case T-470/13 (Merck v Commission) ; Case T-471/13 (Xellia Pharmaceuticals and Alpharma/Commjssion) (not available online); and Case T-472/13 (Lundbeck/Commission). It is recalled that the European Commission imposed a fine of €93.8

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, Pay for delay : The General Court of the European Union confirms the Commission’s approach (Lundbeck), 8 September 2016, Concurrences Nº 4-2016, Art. N° 82207, www.concurrences.com

Visites 303

All reviews